Use of Antiepileptic Drugs in Patients with Chronic Kidney Disease and End Stage Renal Disease

被引：26
作者：
Bansal, Amar D. [1 ]
Hill, Chloe E. [2 ]
Berns, Jeffrey S. [1 ]
机构：
[1] Univ Penn, Renal Electrolyte & Hypertens Div, Perelman Sch Med, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA
来源：
SEMINARS IN DIALYSIS | 2015年 / 28卷 / 04期
关键词：
GRANULOMATOUS INTERSTITIAL NEPHRITIS; ANTIDIURETIC-HORMONE SECRETION; HIGH-FLUX HEMODIALYSIS; PROTEIN-BINDING; PERITONEAL-DIALYSIS; PHARMACOKINETICS; CARBAMAZEPINE; LAMOTRIGINE; TOPIRAMATE; GABAPENTIN;
D O I：
10.1111/sdi.12385
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Epilepsy is a disorder with an approximate worldwide prevalence of 1%. Due to complexities of metabolism, protein-binding, renal elimination, and other pharmacokinetic parameters, the dosing of antiepileptic drugs (AEDs) in patients with chronic kidney disease (CKD) or end stage renal disease (ESRD) deserves special attention. This is a review of the most commonly prescribed AEDs with special focus on their indication, pharmacokinetics, and unique considerations for use in patients with CKD and ESRD. A review of their renal toxicities is also included.
引用
收藏
页码：404 / 412
页数：9
相关论文
共 111 条
[1]   Hypokalemia and hypomagnesaemia related to levetiracetam use [J].
Aksoy, Durdane ;
Cevik, Betul ;
Kurt, Semiha ;
Pekdas, Elmas ;
Solmaz, Volkan .
JOURNAL OF CLINICAL NEUROSCIENCE, 2014, 21 (11) :1989-1990
[2]   Pharmacokinetic of Antiepileptic Drugs in Patients with Hepatic or Renal Impairment [J].
Anderson, Gail D. ;
Hakimian, Shahin .
CLINICAL PHARMACOKINETICS, 2014, 53 (01) :29-49
[3]  
Asconape Jorge J, 2014, Handb Clin Neurol, V119, P417, DOI 10.1016/B978-0-7020-4086-3.00027-8
[4]   A missed opportunity - consequences of unknown levetiracepam pharmacokinetics in a peritoneal dialysis patient [J].
Bahte, Svenja K. ;
Hiss, Marcus ;
Lichtinghagen, Ralf ;
Kielstein, Jan T. .
BMC NEPHROLOGY, 2014, 15
[5]  
Bansal Vinod K, 2014, Handb Clin Neurol, V119, P395, DOI 10.1016/B978-0-7020-4086-3.00025-4
[6]   SEIZURES AND RENAL FAILURES [J].
BERGEN, DC ;
RISTANOVIC, R ;
GORELICK, PB ;
KATHPALIA, S .
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1994, 17 (05) :247-251
[7]   Drug therapy - Antiepileptic drugs [J].
Brodie, MJ ;
Dichter, MA .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (03) :168-175
[8]   Pharmacokinetics of antiepileptic drugs [J].
Browne, TR .
NEUROLOGY, 1998, 51 (05) :S2-S7
[9]   GABAPENTIN AND LAMOTRIGINE - NOVEL ANTIEPILEPTIC DRUGS [J].
BTAICHE, IF ;
WOSTER, PS .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1995, 52 (01) :61-69
[10]   Impact of Impaired Renal Function on the Pharmacokinetics of the Antiepileptic Drug Lacosamide [J].
Cawello, Willi ;
Fuhr, Uwe ;
Hering, Ursula ;
Maatouk, Haidar ;
Halabi, Atef .
CLINICAL PHARMACOKINETICS, 2013, 52 (10) :897-906
12345678910